Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1996-12-31
2000-02-22
Fredman, Jeffrey
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 243, 435 6, 4352402, 4353201, 514 44, C07H 2102, C07H 2104, C12N 510, C12N 1570
Patent
active
060281847
ABSTRACT:
The present invention relates to a novel method for testing the developmel status in pancreatic cells of a mammal. The present invention further relates to applications in the medical field that directly arise from the method of the invention. Additionally, the present invention relates to transgenic mammals comprising at least one inactivated Pax6 allele and optionally at least one inactivated Pax4 allele.
REFERENCES:
Walther et al. Development 113:1435-1450, 1991.
Correll et al. Human Gene Therapy 1: 277-287, 1990.
Paillard, Human Gene Therapy 8:2009-2010, 1997.
Orkin, Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy, 1995.
Gruss Peter
St.-Onge Luc
Fredman Jeffrey
Kowalski Thomas J.
Max-Plank-Gesellschaft zur Forderung der Wissenschaften e.V.
LandOfFree
Pax6 and Pax4 nucleic acid mixtures does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pax6 and Pax4 nucleic acid mixtures, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pax6 and Pax4 nucleic acid mixtures will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-521594